Authors:
LOEWENSTEINLICHTENSTEIN Y
GLICK D
GLUZMAN N
STERNFELD M
ZAKUT H
SOREQ H
Citation: Y. Loewensteinlichtenstein et al., OVERLAPPING DRUG-INTERACTION SITES OF HUMAN BUTYRYLCHOLINESTERASE DISSECTED BY SITE-DIRECTED MUTAGENESIS, Molecular pharmacology, 50(6), 1996, pp. 1423-1431
Authors:
SAULNIERBLACHE JS
YANG Q
SHERLOCK JD
LANIER SM
Citation: Js. Saulnierblache et al., ANALYSIS OF THE ALPHA(2C)-ADRENERGIC RECEPTOR GENE PROMOTER AND ITS CELL-TYPE-SPECIFIC ACTIVITY, Molecular pharmacology, 50(6), 1996, pp. 1432-1442
Authors:
HOHENEGGER M
MATYASH M
POUSSU K
HERRMANNFRANK A
SARKOZI S
LEHMANNHORN F
FREISSMUTH M
Citation: M. Hohenegger et al., ACTIVATION OF THE SKELETAL-MUSCLE RYANODINE RECEPTOR BY SURAMIN AND SURAMIN ANALOGS, Molecular pharmacology, 50(6), 1996, pp. 1443-1453
Authors:
ZHANG JZ
WATSON AJ
PROBST MR
MINEHART E
HANKINSON O
Citation: Jz. Zhang et al., BASIS FOR THE LOSS OF ARYL-HYDROCARBON RECEPTOR GENE-EXPRESSION IN CLONES OF A MOUSE HEPATOMA-CELL LINE, Molecular pharmacology, 50(6), 1996, pp. 1454-1462
Authors:
CORNAROTTI M
TINELLI S
WILLMORE E
ZUNINO F
FISHER LM
AUSTIN CA
CAPRANICO G
Citation: M. Cornarotti et al., DRUG-SENSITIVITY AND SEQUENCE SPECIFICITY OF HUMAN RECOMBINANT-DNA TOPOISOMERASES II-ALPHA (P170) AND II-BETA (P180), Molecular pharmacology, 50(6), 1996, pp. 1463-1471
Citation: A. Fujimori et al., ACQUIRED CAMPTOTHECIN RESISTANCE OF HUMAN BREAST-CANCER MCF-7 C4 CELLS WITH NORMAL TOPOISOMERASE-I AND ELEVATED DNA-REPAIR/, Molecular pharmacology, 50(6), 1996, pp. 1472-1478
Citation: Dj. Macewan et G. Milligan, INVERSE AGONIST-INDUCED UP-REGULATION OF THE HUMAN BETA(2)-ADRENOCEPTOR IN TRANSFECTED NEUROBLASTOMA X GLIOMA HYBRID-CELLS, Molecular pharmacology, 50(6), 1996, pp. 1479-1486
Authors:
STEWART AJ
PICHON C
MEUNIER L
MIDOUX P
MONSIGNY M
ROCHE AC
Citation: Aj. Stewart et al., ENHANCED BIOLOGICAL-ACTIVITY OF ANTISENSE OLIGONUCLEOTIDES COMPLEXED WITH GLYCOSYLATED POLY-L-LYSINE, Molecular pharmacology, 50(6), 1996, pp. 1487-1494
Citation: Yj. Xu et al., INHIBITION OF CAPACITATIVE CA2+ ENTRY INTO CELLS BY FARNESYLCYSTEINE ANALOGS, Molecular pharmacology, 50(6), 1996, pp. 1495-1501
Citation: T. Cihlar et Ms. Chen, IDENTIFICATION OF ENZYMES CATALYZING 2-STEP PHOSPHORYLATION OF CIDOFOVIR AND THE EFFECT OF CYTOMEGALOVIRUS-INFECTION ON THEIR ACTIVITIES INHOST-CELLS, Molecular pharmacology, 50(6), 1996, pp. 1502-1510
Authors:
ANDREWS AM
LADENHEIM B
EPSTEIN CJ
CADET JL
MURPHY DL
Citation: Am. Andrews et al., TRANSGENIC MICE WITH HIGH-LEVELS OF SUPEROXIDE-DISMUTASE ACTIVITY AREPROTECTED FROM THE NEUROTOXIC EFFECTS OF 2'-NH2-MPTP ON SEROTONERGIC AND NORADRENERGIC NERVE-TERMINALS, Molecular pharmacology, 50(6), 1996, pp. 1511-1519
Citation: J. Magyar et G. Szabo, EFFECTS OF VOLATILE ANESTHETICS ON THE G-PROTEIN-REGULATED MUSCARINICPOTASSIUM CHANNEL, Molecular pharmacology, 50(6), 1996, pp. 1520-1528
Authors:
YAO SYM
NG AML
RITZEL MWL
GATI WP
CASS CE
YOUNG JD
Citation: Sym. Yao et al., TRANSPORT OF ADENOSINE BY RECOMBINANT PURINE-SELECTIVE AND PYRIMIDINE-SELECTIVE SODIUM NUCLEOSIDE COTRANSPORTERS FROM RAT JEJUNUM EXPRESSEDIN XENOPUS-LAEVIS OOCYTES/, Molecular pharmacology, 50(6), 1996, pp. 1529-1535
Authors:
VASEY PA
JONES NA
JENKINS S
DIVE C
BROWN R
Citation: Pa. Vasey et al., CISPLATIN, CAMPTOTHECIN, AND TAXOL SENSITIVITIES OF CELLS WITH P53-ASSOCIATED MULTIDRUG-RESISTANCE, Molecular pharmacology, 50(6), 1996, pp. 1536-1540
Authors:
ILYIN VI
WHITTEMORE ER
GUASTELLA J
WEBER E
WOODWARD RM
Citation: Vi. Ilyin et al., SUBTYPE-SELECTIVE INHIBITION OF N-METHYL-D-ASPARTATE RECEPTORS BY HALOPERIDOL, Molecular pharmacology, 50(6), 1996, pp. 1541-1550
Citation: Pg. Bray et al., 4-AMINOQUINOLINE RESISTANCE OF PLASMODIUM-FALCIPARUM - INSIGHTS FROM THE STUDY OF AMODIAQUINE UPTAKE, Molecular pharmacology, 50(6), 1996, pp. 1551-1558
Citation: Pg. Bray et al., PHYSICOCHEMICAL PROPERTIES CORRELATED WITH DRUG-RESISTANCE AND THE REVERSAL OF DRUG-RESISTANCE IN PLASMODIUM-FALCIPARUM, Molecular pharmacology, 50(6), 1996, pp. 1559-1566
Authors:
LEYSEN JE
GOMMEREN W
HEYLEN L
LUYTEN WHML
VANDEWEYER I
VANHOENACKER P
HAEGEMAN G
SCHOTTE A
VANGOMPEL P
WOUTERS R
LESAGE AS
Citation: Je. Leysen et al., ALNIDITAN, A NEW 5-HYDROXYTRYPTAMINE(1D) AGONIST AND MIGRAINE-ABORTIVE AGENT - LIGAND-BINDING PROPERTIES OF HUMAN 5-HYDROXYTRYPTAMINE(1D-ALPHA), HUMAN 5-HYDROXYTRYPTAMINE(1D-BETA), AND CALF 5-HYDROXYTRYPTAMINE(1D) RECEPTORS INVESTIGATED WITH [H-3] 5-HYDROXYTRYPTAMINE AND [H-3] ALNIDITAN, Molecular pharmacology, 50(6), 1996, pp. 1567-1580
Authors:
WITTMER LL
HU YF
KALKBRENNER M
EVERS AS
ZORUMSKI CF
COVEY DF
Citation: Ll. Wittmer et al., ENANTIOSELECTIVITY OF STEROID-INDUCED GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR MODULATION AND ANESTHESIA, Molecular pharmacology, 50(6), 1996, pp. 1581-1586
Authors:
FIGLER RA
GRABER SG
LINDORFER MA
YASUDA H
LINDEN J
GARRISON JC
Citation: Ra. Figler et al., RECONSTITUTION OF RECOMBINANT BOVINE A(1) ADENOSINE RECEPTORS IN SF9 CELL-MEMBRANES WITH RECOMBINANT G-PROTEINS OF DEFINED COMPOSITION, Molecular pharmacology, 50(6), 1996, pp. 1587-1595
Authors:
FONG TM
YU H
HUANG RRC
CASCIERI MA
SWAIN CJ
Citation: Tm. Fong et al., RELATIVE CONTRIBUTION OF POLAR INTERACTIONS AND CONFORMATIONAL COMPATIBILITY TO THE BINDING OF NEUROKININ-1 RECEPTOR ANTAGONISTS, Molecular pharmacology, 50(6), 1996, pp. 1605-1611
Citation: Kj. Reszka et Cf. Chignell, ACID-CATALYZED OXIDATION OF THE ANTICANCER AGENT MITOXANTRONE BY NITRITE IONS, Molecular pharmacology, 50(6), 1996, pp. 1612-1618
Authors:
VARGA EV
LI XP
STROPOVA D
ZALEWSKA T
LANDSMAN RS
KNAPP RJ
MALATYNSKA E
KAWAI K
MIZUSURA A
NAGASE H
CALDERON SN
RICE K
HRUBY VJ
ROESKE WR
YAMAMURA HI
Citation: Ev. Varga et al., THE 3RD EXTRACELLULAR LOOP OF THE HUMAN DELTA-OPIOID RECEPTOR DETERMINES THE SELECTIVITY OF DELTA-OPIOID AGONISTS, Molecular pharmacology, 50(6), 1996, pp. 1619-1624
Citation: H. Rauer et S. Grissmer, EVIDENCE OF AN INTERNAL PHENYLALKYLAMINE ACTION ON THE VOLTAGE-GATED POTASSIUM CHANNEL KV1.3, Molecular pharmacology, 50(6), 1996, pp. 1625-1634